BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34161779)

  • 1. A Novel N-terminal Region to Chromodomain in CHD7 is Required for the Efficient Remodeling Activity.
    Lee E; Kang C; Purhonen P; Hebert H; Bouazoune K; Hohng S; Song JJ
    J Mol Biol; 2021 Sep; 433(18):167114. PubMed ID: 34161779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ATP-dependent chromatin remodeling enzymes CHD6, CHD7, and CHD8 exhibit distinct nucleosome binding and remodeling activities.
    Manning BJ; Yusufzai T
    J Biol Chem; 2017 Jul; 292(28):11927-11936. PubMed ID: 28533432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin remodeling by the CHD7 protein is impaired by mutations that cause human developmental disorders.
    Bouazoune K; Kingston RE
    Proc Natl Acad Sci U S A; 2012 Nov; 109(47):19238-43. PubMed ID: 23134727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence and functional differences in the ATPase domains of CHD3 and SNF2H promise potential for selective regulability and drugability.
    Hoffmeister H; Fuchs A; Komives E; Groebner-Ferreira R; Strobl L; Nazet J; Heizinger L; Merkl R; Dove S; Längst G
    FEBS J; 2021 Jul; 288(13):4000-4023. PubMed ID: 33403747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHD7 regulates cardiovascular development through ATP-dependent and -independent activities.
    Yan S; Thienthanasit R; Chen D; Engelen E; Brühl J; Crossman DK; Kesterson R; Wang Q; Bouazoune K; Jiao K
    Proc Natl Acad Sci U S A; 2020 Nov; 117(46):28847-28858. PubMed ID: 33127760
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyruvate Kinase M2 serves as blockade for nucleosome repositioning and abrogates Chd7 remodeling activity.
    Verma K; Patel A
    PLoS One; 2019; 14(2):e0211515. PubMed ID: 30735509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CHD2 is a chromatin assembly ATPase regulated by its chromo- and DNA-binding domains.
    Liu JC; Ferreira CG; Yusufzai T
    J Biol Chem; 2015 Jan; 290(1):25-34. PubMed ID: 25384982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional Insights into Chromatin Remodelling from Studies on CHARGE Syndrome.
    Basson MA; van Ravenswaaij-Arts C
    Trends Genet; 2015 Oct; 31(10):600-611. PubMed ID: 26411921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HERVH-derived lncRNAs negatively regulate chromatin targeting and remodeling mediated by CHD7.
    Hsieh FK; Ji F; Damle M; Sadreyev RI; Kingston RE
    Life Sci Alliance; 2022 Jan; 5(1):. PubMed ID: 34663690
    [No Abstract]   [Full Text] [Related]  

  • 10. The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping.
    Quan J; Yusufzai T
    J Biol Chem; 2014 Jul; 289(30):20717-26. PubMed ID: 24923445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Non-Catalytic Domains of Hrp3 in Nucleosome Remodeling.
    Dong W; Prasad P; Lennartsson A; Ekwall K
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.
    Lehmann LC; Hewitt G; Aibara S; Leitner A; Marklund E; Maslen SL; Maturi V; Chen Y; van der Spoel D; Skehel JM; Moustakas A; Boulton SJ; Deindl S
    Mol Cell; 2017 Dec; 68(5):847-859.e7. PubMed ID: 29220652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotranscriptomic meta-analysis of the CHD family chromatin remodelers in human cancers - initial evidence of an oncogenic role for CHD7.
    Chu X; Guo X; Jiang Y; Yu H; Liu L; Shan W; Yang ZQ
    Mol Oncol; 2017 Oct; 11(10):1348-1360. PubMed ID: 28649742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidation of the functional roles of the Q and I motifs in the human chromatin-remodeling enzyme BRG1.
    Hoffmeister H; Fuchs A; Strobl L; Sprenger F; Gröbner-Ferreira R; Michaelis S; Hoffmann P; Nazet J; Merkl R; Längst G
    J Biol Chem; 2019 Mar; 294(9):3294-3310. PubMed ID: 30647132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHARGE syndrome protein CHD7 regulates epigenomic activation of enhancers in granule cell precursors and gyrification of the cerebellum.
    Reddy NC; Majidi SP; Kong L; Nemera M; Ferguson CJ; Moore M; Goncalves TM; Liu HK; Fitzpatrick JAJ; Zhao G; Yamada T; Bonni A; Gabel HW
    Nat Commun; 2021 Sep; 12(1):5702. PubMed ID: 34588434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chd1 chromatin remodelers maintain nucleosome organization and repress cryptic transcription.
    Hennig BP; Bendrin K; Zhou Y; Fischer T
    EMBO Rep; 2012 Nov; 13(11):997-1003. PubMed ID: 23032292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-targeted nucleosome sliding in vivo by a hybrid Chd1 chromatin remodeler.
    McKnight JN; Tsukiyama T; Bowman GD
    Genome Res; 2016 May; 26(5):693-704. PubMed ID: 26993344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation update on the CHD7 gene involved in CHARGE syndrome.
    Janssen N; Bergman JE; Swertz MA; Tranebjaerg L; Lodahl M; Schoots J; Hofstra RM; van Ravenswaaij-Arts CM; Hoefsloot LH
    Hum Mutat; 2012 Aug; 33(8):1149-60. PubMed ID: 22461308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHD7 cooperates with PBAF to control multipotent neural crest formation.
    Bajpai R; Chen DA; Rada-Iglesias A; Zhang J; Xiong Y; Helms J; Chang CP; Zhao Y; Swigut T; Wysocka J
    Nature; 2010 Feb; 463(7283):958-62. PubMed ID: 20130577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acidic patch histone mutations and their effects on nucleosome remodeling.
    Dao HT; Pham LTD
    Biochem Soc Trans; 2022 Apr; 50(2):907-919. PubMed ID: 35356970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.